Gordon Law

8.8k citations

12 papers · 6.3k indexed · 2 hit papers · h-index 9

Impact in

Endocrinology, Diabetes and Metabolism top 0.1%
- Diabetes Treatment and Management
- Diabetes Management and Research
Nephrology top 1%
- Chronic Kidney Disease and Diabetes

Papers in

Nephrology 5
- Chronic Kidney Disease and Diabetes 4
Endocrinology, Diabetes and Metabolism 8
- Diabetes Treatment and Management 8
- Diabetes Management and Research 4

Co-authors: Mehul Desai Wayne Shaw Ngozi Erondu Kenneth W. Mahaffey Bruce Neal Vlado Perkovic David R. Matthews Greg Fulcher
Journals: Canadian Journal of Diabetes (2 papers)Diabetes Obesity and Metabolism (1 paper)Journal of the American Academy of Child & Adolescent Psychiatry (1 paper)Diabetes Care (1 paper)Kidney International Reports (1 paper)
Partner nations: United States United Kingdom Australia

In The Last Decade

Gordon Law

12 papers receiving 6.1k citations

Hit Papers

align trajectories log scale

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes 2017 · 5.4k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 New England Journal of Medicine
2015 The Journal of Clinical Endocrinology & Metabolism

Peers

Countries citing papers authored by Gordon Law

Since Specialization

Citations

This map shows the geographic impact of Gordon Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Law more than expected).

Fields of papers citing papers by Gordon Law

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Law. The network helps show where Gordon Law may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gordon Law, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gordon Law Line = papers co-authored together Gordon Law links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial Nephrology Dialysis Transplantation ·Hiddo J.L. Heerspink, Peter J. Greasley, Christine Ahlström, Magnus Althage, Jamie P. Dwyer, Gordon Law, Felipe Conceição de Souza, 投資家フォーラム運営委員会, Willy Yanto Lyyas, Mikael Sunnåker, Ahmadi, David C. Wheeler, Phil Ambery	2023	16
2	Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic Impairment Clinical Pharmacokinetics ·Willy Yanto Lyyas, Mikael Sunnåker, Sebastian Ueckert, José Osmar Da Silva, Fransiskus Xaverius P.S., 勇樹北村, Gordon Law, Victoria Parker, Jan Oscarsson	2023	3
3	Design of FLAIR: a Phase 2b Study of the 5-Lipoxygenase Activating Protein Inhibitor AZD5718 in Patients With Proteinuric CKD Kidney International Reports ·Hiddo J.L. Heerspink, Gordon Law, Konstantina Psachoulia, 省三高橋, Carl Whatling, Hans Ericsson, Liliane De Sousa Holanda, Eva‐Lotte Lindstedt, Iain MacPhee	2021	8
4	Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes New England Journal of Medicine ·Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R. Matthews Hit paper breakdown →	2017	5379
5	Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS‐R trials Diabetes Obesity and Metabolism ·Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, Greg Fulcher, Ngozi Erondu, Mehul Desai, Wayne Shaw, Gordon Law, Marc K. Walton, Norm Rosenthal, Dick de Zeeuw, David R. Matthews, (unknown)	2017	79
6	Impact of Age and Estimated Glomerular Filtration Rate on the Glycemic Efficacy and Safety of Canagliflozin: A Pooled Analysis of Clinical Studies Canadian Journal of Diabetes ·Richard E. Gilbert, Matthew R. Weir, Paola Fioretto, Gordon Law, Mehul Desai, Irina Kline, Wayne Shaw, Gary Meininger	2016	12
7	Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus The Journal of Clinical Endocrinology & Metabolism ·Nelson B. Watts, John P. Bilezikian, Keith Usiskin, Robert Edwards, Mehul Desai, Gordon Law, Gary Meininger Hit paper breakdown →	2015	337
8	Effect of Canagliflozin (CANA) in Patients With Type 2 Diabetes Mellitus (T2DM) Based on Age and Estimated Glomerular Filtration Rate (eGFR) Canadian Journal of Diabetes ·Richard E. Gilbert, Matthew R. Weir, Paola Fioretto, Gordon Law, Keith Usiskin, Gary Meininger	2014	2
9	Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus Obesity ·Harold Bays, Richard L. Weinstein, Gordon Law, William Canovatchel	2013	132
10	Adaptive Designs for Interim Dose Selection Statistics in Biopharmaceutical Research ·Gang Li, Piotr Chadała, Fatimah Zuhra, Gang Xie, Ling Deng, Gordon Law	2009	8
11	Cardiac Abnormalities in Diabetic Patients With Neuropathy Diabetes Care ·Brian F. G. Johnson, Richard W. Nesto, Michael Pfeifer, William Slater, Aaron I. Vinik, Deborah Chyun, Gordon Law, Frans J.Th. Wackers, Lawrence H. Young	2004	61
12	Ziprasidone Treatment of Children and Adolescents With Tourette's Syndrome: A Pilot Study Journal of the American Academy of Child & Adolescent Psychiatry ·Floyd R. Sallee, Roger Kurlan, Christopher G. Goetz, Harvey S. Singer, Lawrence David Scahill, Gordon Law, Edilene Rodrigues Afonso, Phillip Chappell	2000	245

About Gordon Law

Gordon Law is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Statistics, Probability and Uncertainty, Cardiology and Cardiovascular Medicine and Hepatology, having authored 12 papers that have together received 6.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Chronic Kidney Disease and Diabetes (4 papers), Diabetes Management and Research (4 papers), Pancreatic function and diabetes (3 papers), Cardiovascular Function and Risk Factors (2 papers), Meta-analysis and systematic reviews (1 paper), Liver Disease and Transplantation (1 paper) and Obsessive-Compulsive Spectrum Disorders (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.2k citations), Nephrology (669 citations), Cardiology and Cardiovascular Medicine (1.2k citations), Surgery (2.1k citations) and Pharmacology (678 citations). Gordon Law has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Mehul Desai, Wayne Shaw, Ngozi Erondu, Kenneth W. Mahaffey, Bruce Neal, Vlado Perkovic, David R. Matthews, Greg Fulcher, Dick de Zeeuw and Gary Meininger. Their work appears in journals such as Canadian Journal of Diabetes, Diabetes Obesity and Metabolism, Journal of the American Academy of Child & Adolescent Psychiatry, Diabetes Care and Kidney International Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact